....after writing down the jv, including a 20% reduction in assets and doing a 1 for 1 equity raising @ 60c GPT will be worth $1.30
If you take up the rights issue you will be buying shares at a 53% discount to the NTA
with a stronger balance sheet and a discount of the assets you can expect the NTA to close to actual value
please check out my calculations
v
v
v
the original NTA was $3.82
equity = $8.4 bn
no of shares = 2.2 bn
$8.4bn/2.2bn = $3.82
assets $14 bn
debts $5.6
equity $8.4
$2bn was leant to the jv
jv
assets $7 bn
debt $5 bn
equity $2bn
1. the JV has been written down to zero
you therefore have to knock off $2bn from the balance sheet
eg
assets $12bn
debts $5.6 bn
equity$6.4
2. next include 2O% reduction in assets
assets $10bn
debts $5.6bn
equity $4.4bn
3. finally include a 1 for 1 equity raising @ 60c
2bn shares x .60 = $1.3 bn
assets $11.3 bn
debts $5.6 bn
equity $5.7 bn
equity $5.7 bn
no of shares = 4.4 bn
nta = $1.30
gearing = 49.5%
- Forums
- ASX - By Stock
- GPT
- what is going to be worth
GPT
gpt group
Add to My Watchlist
0.79%
!
$5.10

what is going to be worth
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.10 |
Change
0.040(0.79%) |
Mkt cap ! $9.769B |
Open | High | Low | Value | Volume |
$5.06 | $5.13 | $5.06 | $33.90M | 6.648M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4468 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.13 | 4468 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 5.070 |
1 | 180 | 5.050 |
1 | 100 | 5.010 |
1 | 200 | 4.950 |
1 | 3093 | 4.940 |
Price($) | Vol. | No. |
---|---|---|
5.140 | 1100 | 1 |
5.150 | 146286 | 6 |
5.170 | 426 | 1 |
5.180 | 700 | 1 |
5.190 | 378 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
GPT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online